Milk Allergy
15
2
2
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.7%
1 terminated out of 15 trials
90.0%
+3.5% vs benchmark
7%
1 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (15)
Comparison Between a Rush and a Conventional Oral Immunotherapy Protocol to Treat Cow's Milk and Hen´s Egg Allergy. CompITO Study
A Long Term, Observational Follow-Up Study of Children and Young People Who Underwent an 18-Month Course of Oral Immunotherapy Treatment for Peanut, Egg or Milk Allergy (5-15 Years Post-Treatment)
The Clinical Impact of the Basophil Activation Test to Diagnose Food Allergy
Characteristic and Evolution of an Atypical IgE-mediated Cow Milk Allergy Form With Hands and Feet Angio-oedema
The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy
Basophil Activation Test to Diagnose Food Allergy
OIT and Xolair® (Omalizumab) in Cow's Milk Allergy
Swedish Study of Immunotherapy for Milk Allergy in Children
Milk Patch for Eosinophilic Esophagitis
Xolair Treatment for Milk Allergic Children
Impact of Infant Formula on Resolution of Cow's Milk Allergy
Formula for Children With Cow's Milk Allergy
The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy
Safety of Oral Immunotherapy for Cow's Milk Allergy in School-aged Children
Milk ALLERGY ELIMINATION THROUGH NAET® (Nambudripad's Allergy Elimination Techniques).